Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Apr 30;5(12):1114–1122. doi: 10.1016/j.bpsc.2020.04.012

Table 1.

Demographics, contraceptive use, smoking status, and psychiatric medication use correlated with salivary estradiol level. All participants prescribed acute-acting psychotropic medications (stimulants, benzodiazepines, etc.) refrained from taking that medication on the day of the scan. All scans occurred between the hours of 1:00 — 7:00pm. The racial categories used by the US Census (African-American, Asian-American, Native-American, Latinx, and Pacific Islander) are included in the category “non-White.” Digit span is from the Wechsler Adult Intelligence Scale-IV. GAD = Generalized Anxiety Disorder. CAPS = Clinician Administered PTSD Scale. A value followed by s indicates a statistically significant Spearman correlation (p < .05).

Variable Participants N=42 p values
Age (yr) 30.8 (8.2) .721
Education (yr) 16.2 (2.4) .258
BMI 27.2 (6.4) .908
Non-White Ethnicity (%) 21.4 .502
Digit span 10.0 (2.7) .709
Direct assault types (#) 4.6 (2.5) .187
Sexual assault (%) 92.9 .636
Physical assault (%) 78.6 .363
Physical abuse (%) 50.0 .732
Age first assault (yr) 10.2 (6.4) .317
Age last assault (yr) 25.5 (8.5) .285
Time since last assault (yr) 5.4 (6.7) .067
Current mood disorder (%) 35.7 .262
Current anxiety disorder (%) 76.2 .756
Current GAD (%) 57.1 .364
CAPS total severity 41.5 (10.8) .818
Contraceptive (%)
Oral contraceptive 9.5 .180
Hormonal IUD 28.6 .824
Tubal ligation 7.1 .938
Depo Provera 2.4 .965
Nexplanon 2.4 .222
NuvaRing 2.4 .828
Any 52.4 .805
Daily cigarette smoker (%) 11.9 .450
Psychotropic medication (%)
Antidepressants 7.1 .890
SSRI 26.2 .132
SNRI 7.1 .001s
NDRI 11.9 .475
Mood 4.8 .493
stabilizer/antipsychotic
Benzo 2.4 .401
Stimulants 9.5 .890
Anticonvulsant 7.1 .695
Antianxiety 7.1 .889
Any psychotropic med 45.2 .514